Amitava Dasgupta
#149,553
Most Influential Person Now
Researcher
Amitava Dasgupta's AcademicInfluence.com Rankings
Amitava Dasguptaengineering Degrees
Engineering
#5994
World Rank
#7284
Historical Rank
Electrical Engineering
#1729
World Rank
#1827
Historical Rank
Amitava Dasguptacomputer-science Degrees
Computer Science
#7761
World Rank
#8167
Historical Rank
Data Science
#163
World Rank
#166
Historical Rank
Computational Linguistics
#1619
World Rank
#1636
Historical Rank
Machine Learning
#2983
World Rank
#3020
Historical Rank
Download Badge
Engineering Computer Science
Amitava Dasgupta's Degrees
- PhD Computer Science Stanford University
Similar Degrees You Can Earn
Why Is Amitava Dasgupta Influential?
(Suggest an Edit or Addition)Amitava Dasgupta's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management. (2007) (147)
- Increased lipid peroxidation in patients on maintenance hemodialysis. (1992) (115)
- Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blocking. (2002) (91)
- Absorption of therapeutic drugs by barrier gels in serum separator blood collection tubes. Volume- and time-dependent reduction in total and free drug concentrations. (1994) (88)
- The effects of adulterants and selected ingested compounds on drugs-of-abuse testing in urine. (2007) (83)
- False-positive troponin I in the MEIA due to the presence of rheumatoid factors in serum. Elimination of this interference by using a polyclonal antisera against rheumatoid factors. (1999) (81)
- Clinical Utility of Free Drug Monitoring (2002) (71)
- Rapid automated determination of lipid hydroperoxide concentrations and total antioxidant status of serum samples from patients infected with HIV: elevated lipid hydroperoxide concentrations and depleted total antioxidant capacity of serum samples. (1998) (63)
- Pharmacokinetic and Other Drug Interactions in Patients With AIDS (2001) (61)
- In vitro lipid peroxidation of human serum catalyzed by cupric ion: antioxidant rather than prooxidant role of ascorbate. (1992) (59)
- Cadmium exposure. (2011) (57)
- Comparison of BD Vacutainer SST Plus Tubes with BD SST II Plus Tubes for common analytes. (2001) (55)
- Improved Oil Recovery (2001) (53)
- Comparison of immunoreactivity of five human cardiac troponin I assays toward free and complexed forms of the antigen: implications for assay discordance. (1999) (53)
- Decreased total antioxidant capacity and elevated lipid hydroperoxide concentrations in sera of epileptic patients receiving phenytoin. (1997) (51)
- Immune modulation of macrophage pro-inflammatory response by goldenseal and Astragalus extracts. (2008) (51)
- Rapid Detection of Oleander Poisoning Using Digoxin Immunoassays: Comparison of Five Assays (2004) (51)
- Stability of therapeutic drug measurement in specimens collected in VACUTAINER plastic blood-collection tubes. (1996) (50)
- Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. (2003) (49)
- Decreased total antioxidant capacity but normal lipid hydroperoxide concentrations in sera of critically ill patients. (1996) (48)
- Time-dependent absorption of therapeutic drugs by the gel of the Greiner Vacuette blood collection tube. (2000) (48)
- Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): a proposal. (2006) (48)
- Cytokine production by non-adherent mouse splenocyte cultures to Echinacea extracts. (2004) (47)
- Herbal remedies: effects on clinical laboratory tests. (2006) (47)
- Asian and Siberian ginseng as a potential modulator of immune function: an in vitro cytokine study using mouse macrophages. (2003) (47)
- Effect of the traditional chinese medicines Chan Su, Lu‐Shen‐Wan, Dan Shen, and Asian Ginseng on Serum Digoxin measurement by Tina‐quant (Roche) and Synchron LX system (Beckman) digoxin immunoassays (2003) (46)
- Chapter 2 – Methods for Measuring Oxidative Stress in the Laboratory (2014) (46)
- Therapeutic Drug Monitoring of Mycophenolic Acid. (2016) (45)
- Antioxidants in Food, Vitamins and Supplements: Prevention and Treatment of Disease (2014) (45)
- Stability of Therapeutic Drugs in Serum Collected in Vacutainer Serum Separator Tubes Containing a New Gel (SST II) (2001) (45)
- Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients. (1991) (44)
- Positive and negative interference of the Chinese medicine Chan Su in serum digoxin measurement. Elimination of interference by using a monoclonal chemiluminescent digoxin assay or monitoring free digoxin concentration. (2000) (44)
- Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing. (2002) (42)
- Effect of Asian and Siberian ginseng on serum digoxin measurement by five digoxin immunoassays. Significant variation in digoxin-like immunoreactivity among commercial ginsengs. (2003) (41)
- Improved lipid profiles in patients undergoing high-flux hemodialysis. (1992) (40)
- Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin. (2002) (40)
- Review of Abnormal Laboratory Test Results and Toxic Effects Due to Use of Herbal Medicines (2003) (39)
- Displacement of phenytoin from serum protein carriers by antibiotics: studies with ceftriaxone, nafcillin, and sulfamethoxazole. (1991) (39)
- Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein. (2000) (38)
- Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens. (2004) (37)
- Apoptosis is associated with an increase in saturated fatty acid containing phospholipids in the neuronal cell line, HN2-5. (1996) (37)
- Gas chromatographic-mass spectrometric identification and quantification of aniline after extraction from serum and derivatization with 2,2,2-trichloroethyl chloroformate, a novel derivative. (1998) (37)
- Effect of Chinese Medicines Chan Su and Danshen on EMIT 2000 and Randox Digoxin Immunoassays: Wide Variation in Digoxin-like Immunoreactivity and Magnitude of Interference in Digoxin Measurement by Different Brands of the Same Product (2002) (36)
- Handbook of drug monitoring methods; therapeutics and drugs of abuse. (2008) (35)
- Neutralization of cardiac toxins oleandrin, oleandrigenin, bufalin, and cinobufotalin by digibind: monitoring the effect by measuring free digitoxin concentrations. (1998) (35)
- Mass spectral behavior and HPLC of some unusual molecular phospholipid species. (1986) (35)
- Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays (2001) (34)
- Herbal Supplements and Therapeutic Drug Monitoring: Focus on Digoxin Immunoassays and Interactions With St. John's Wort (2008) (34)
- Negative interference of bilirubin and hemoglobin in the MEIA troponin I assay but not in the MEIA CK‐MB assay (2001) (33)
- Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay. (1993) (32)
- Suppression of total digoxin concentrations by digoxin-like immunoreactive substances in the MEIA digoxin assay. Elimination of negative interference by monitoring free digoxin concentrations. (1999) (31)
- Use of microwave irradiation for rapid transesterification of lipids and accelerated synthesis of fatty acyl pyrrolidides for analysis by gas chromatography-mass spectrometry: study of fatty acid profiles of olive oil, evening primrose oil, fish oils and phospholipids from mango pulp (1992) (31)
- Accurate Results in the Clinical Laboratory: A Guide to Error Detection and Correction (2013) (30)
- Abnormal fatty acid profile in chronic hemodialysis patients: possible deficiency of essential fatty acids. (1990) (30)
- Therapeutic drug monitoring : newer drugs and biomarkers (2012) (30)
- Antioxidants in food, vitamins and supplements : (2017) (30)
- Enrichment of saturated fatty acid containing phospholipids in sheep brain serotonin receptor preparations: use of microwave irradiation for rapid transesterification of phospholipids. (1992) (30)
- Evaluation of QMS Everolimus Assay Using Hitachi 917 Analyzer: Comparison With Liquid Chromatography/Mass Spectrometry (2011) (29)
- Advances in antibiotic measurement. (2012) (29)
- A rapid cost-effective high-performance liquid chromatographic (HPLC) assay of serum lamotrigine after liquid-liquid extraction and using HPLC conditions routinely used for analysis of barbiturates. (1997) (28)
- Effect of Brazilian, Indian, Siberian, Asian, and North American ginseng on serum digoxin measurement by immunoassays and binding of digoxin-like immunoreactive components of ginseng with Fab fragment of antidigoxin antibody (Digibind). (2005) (28)
- In vitro displacement of phenytoin from protein binding by nonsteroidal antiinflammatory drugs tolmetin, ibuprofen, and naproxen in normal and uremic sera. (1996) (28)
- Elevated free fatty acid concentrations in lipemic sera reduce protein binding of valproic acid significantly more than phenytoin. (1997) (28)
- Positive and negative in vitro interference of Chinese medicine dan shen in serum digoxin measurement. Elimination of interference by monitoring free digoxin concentration. (2001) (27)
- Study on mechanism of action of Chinese medicine Chan Su: dose-dependent biphasic production of nitric oxide in trophoblastic BeWo cells. (2003) (27)
- Evidence for lipase abnormality: high levels of free and triacylglycerol forms of unsaturated fatty acids in neuronal ceroid-lipofuscinosis tissue. (1992) (27)
- Therapeutic Drug Monitoring of Digoxin (2006) (26)
- Lamotrigine analysis in plasma by gas chromatography-mass spectrometry after conversion to a tert.-butyldimethylsilyl derivative. (1997) (26)
- Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer. (1999) (25)
- Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): a proposal. (2006) (25)
- Fatty acid abnormalities in hemodialysis patients: effect of L-carnitine administration. (1989) (25)
- Microwave-induced rapid preparation of fluoro-derivatives of amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine for GC-MS confirmation assays. (1994) (25)
- Herbal toxicity. (2010) (25)
- Effect of Ultrafiltrate Volume on Determination of Free Phenytoin Concentration (2005) (25)
- Two novel endogenous digoxin-like immunoreactive substances isolated from human plasma ultrafiltrate. (1987) (24)
- Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): a proposal. (2006) (24)
- Gas chromatographic-mass spectrometric identification and quantitation of benzyl alcohol in serum after derivatization with perfluorooctanoyl chloride: a new derivative. (1995) (24)
- High performance liquid chromatography and fast atom bombardment mass spectrometry of unusual branched and unsaturated phospholipid molecular species. (1987) (24)
- Neutralization of free digoxin-like immunoreactive components of oriental medicines Dan Shen and Lu-Shen-Wan by the Fab fragment of antidigoxin antibody (Digibind). (2004) (23)
- Impact of Interferences Including Metabolite Crossreactivity on Therapeutic Drug Monitoring Results (2012) (23)
- Phospholipid studies of marine organisms: New branched fatty acids fromStrongylophora durissima (1984) (23)
- Estimation of carbamazepine and carbamazepine-10,11-epoxide concentrations in plasma using mathematical equations generated with two carbamazepine immunoassays. (2010) (23)
- Drug–herb interactions: unexpected suppression of free Danshen concentrations by salicylate (2002) (23)
- False-positive Serum Tricyclic Antidepressant Concentrations Using Fluorescence Polarization Immunoassay Due to the Presence of Hydroxyzine and Cetirizine (2007) (23)
- False-positive ethanol in clinical and postmortem sera by enzymatic assay: elimination of interference by measuring alcohol in protein-free ultrafiltrate. (1994) (22)
- Clinical Chemistry, Immunology and Laboratory Quality Control: A Comprehensive Review for Board Preparation, Certification and Clinical Practice (2014) (22)
- Differential solubilization of membrane lipids by detergents: coenrichment of the sheep brain serotonin 5-HT1A receptor with phospholipids containing predominantly saturated fatty acids. (1993) (21)
- Effect of Asian and Siberian Ginseng on Serum Digoxin Measurement by Five Digoxin Immunoassays (2003) (21)
- Analytical performance of EMIT cyclosporine assay evaluated. (1991) (21)
- OLeandrin Produces Changes in Intracellular Calcium Levels in Isolated Cardiomyocytes: A Real-Time Fluorescence Imaging Study Comparing Adult to Neonatal Cardiomyocytes (2007) (21)
- Rapid detection of oleander poisoning using fluorescence polarization immunoassay for digitoxin. Effect of treatment with digoxin-specific Fab antibody fragment (ovine). (1997) (21)
- Interference of hawthorn on serum digoxin measurements by immunoassays and pharmacodynamic interaction with digoxin. (2010) (21)
- Monitoring free digoxin instead of total digoxin in patients with congestive heart failure and high concentrations of digoxin-like immunoreactive substances. (1990) (21)
- Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus. (1998) (21)
- Increased free phenytoin concentrations in predialysis serum compared to postdialysis serum in patients with uremia treated with hemodialysis. Role of uremic compounds. (1992) (21)
- Stability of NT-proBNP in serum specimens collected in Becton Dickinson Vacutainer (SST) tubes. (2003) (20)
- Microbiology and Molecular Diagnosis in Pathology: A Comprehensive Review for Board Preparation, Certification and Clinical Practice (2017) (20)
- Accurate Results in the Clinical Laboratory (2014) (19)
- Bidirectional (positive/negative) interference in a digoxin immunoassay: importance of antibody specificity. (1998) (19)
- Abbott ARCHITECT Clinical Chemistry and Immunoassay Systems: Digoxin Assays Are Free of Interferences From Spironolactone, Potassium Canrenoate, and Their Common Metabolite Canrenone (2011) (18)
- Distinguishing amphetamine and methamphetamine from other interfering sympathomimetic amines after various fluoro derivatization and analysis by gas chromatography-chemical ionization mass spectrometry (1995) (18)
- Digoxin-like and digitoxin-like immunoreactive substances in elderly people. Impact on therapeutic drug monitoring of digoxin and digitoxin concentrations. (2001) (18)
- Ginseng: Cardiotonic in adult rat cardiomyocytes, cardiotoxic in neonatal rat cardiomyocytes. (2006) (18)
- Overview of Bacteria (2017) (17)
- Alcohol, Drugs, Genes and the Clinical Laboratory: An Overview for Healthcare and Safety Professionals (2016) (17)
- Cytokine mRNA expression and serum cortisol evaluation during murine lung inflammation induced by Mycobacterium tuberculosis. (2000) (17)
- Introduction to Therapeutic Drug Monitoring (2008) (17)
- Comparison of mycophenolic acid concentrations determined by a new PETINIA assay on the dimension EXL analyzer and a HPLC-UV method. (2013) (17)
- Thromboelastography is a suboptimal test for determination of the underlying cause of bleeding associated with cardiopulmonary bypass and may not predict a hypercoagulable state. (2014) (17)
- Advances in Chromatographic Techniques for Therapeutic Drug Monitoring (2009) (17)
- In vivo digoxin-like immunoreactivity in mice and interference of Chinese medicine Danshen in serum digoxin measurement: elimination of interference by using a chemiluminescent assay. (2002) (17)
- Mycobacterial Glycolipid Cord Factor Trehalose 6,6’-Dimycolate Causes a Decrease in Serum Cortisol during the Granulomatous Response (2003) (16)
- Rapid detection of oleander poisoning by Digoxin III, a new Digoxin assay: impact on serum Digoxin measurement. (2008) (16)
- A comparison of the effects of commercially available hawthorn preparations on calcium transients of isolated cardiomyocytes. (2008) (16)
- Clinical Challenges in Therapeutic Drug Monitoring: Special Populations, Physiological Conditions, and Pharmacogenomics (2016) (16)
- Effect of Asian ginseng, Siberian ginseng, and Indian ayurvedic medicine Ashwagandha on serum digoxin measurement by digoxin III, a new digoxin immunoassay (2008) (16)
- Antibiotics, Antimicrobial Resistance, Antibiotic Susceptibility Testing, and Therapeutic Drug Monitoring for Selected Drugs (2017) (16)
- Chapter 15 – Antioxidant Vitamins and Minerals (2014) (16)
- Rapid estimation of whole blood everolimus concentrations using architect sirolimus immunoassay and mathematical equations: comparison with everolimus values determined by liquid chromatography/mass spectrometry (2011) (16)
- Rapid detection of the active cardiac glycoside convallatoxin of lily of the valley using LOCI digoxin assay. (2014) (15)
- Prediction of free phenytoin levels based on [total phenytoin]/[albumin] ratios. Potential errors with hypoalbuminemia. (1991) (15)
- Effect of heating human sera at a temperature necessary to deactivate human immunodeficiency virus on measurement of free phenytoin, free valproic acid, and free carbamazepine concentrations. (1999) (15)
- Effects of digoxinlike immunoreactive substances and digoxin FAB antibodies on the new digoxin microparticle enzyme immunoassay. (1997) (15)
- Phenytoin‐Oxacillin Interactions in Normal and Uremic Sera (1997) (14)
- Analytic Performance Evaluation of a New Turbidimetric Immunoassay for Carbamazepine on the ADVIA 1650 Analyzer: Effect of Carbamazepine 10,11-Epoxide (2005) (14)
- Microwave induced rapid preparation of acetyl, trifluoroacetyl and tert-butyl dimethylsilyl derivatives of fatty alcohols and diacylglycerols for gas chromatography-mass spectrometric analysis (1993) (14)
- Interaction of valproic acid with nonsteroidal antiinflammatory drugs mefenamic acid and fenoprofen in normal and uremic sera: lack of interaction in uremic sera due to the presence of endogenous factors. (1996) (14)
- A New Turbidometric Digoxin Immunoassay on the ADVIA 1650 Analyzer Is Free from Interference by Spironolactone, Potassium Canrenoate, and Their Common Metabolite Canrenone (2003) (13)
- Fast atom bombardment mass spectrometric determination of the molecular weight range of uremic compounds that displace phenytoin from protein binding: absence of midmolecular uremic toxins. (1994) (13)
- Drug-herb interaction: effect of St John's wort on bioavailability and metabolism of procainamide in mice. (2007) (13)
- Analytic Performance Evaluation of a New Turbidimetric Immunoassay for Phenytoin on the ADVIA 1650® Analyzer: Effect of Phenytoin Metabolite and Analogue (2005) (13)
- Abuse of Magic Mushroom, Peyote Cactus, LSD, Khat, and Volatiles (2019) (13)
- Displacement of valproic acid and carbamazepine from protein binding in normal and uremic sera by tolmetin, ibuprofen, and naproxen: presence of inhibitor in uremic serum that blocks valproic acid-naproxen interactions. (1996) (13)
- Bidirectional (positive/negative) interference of spironolactone, canrenone, and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin (2002) (13)
- Limitations of EMIT Benzodiazepine Immunoassay for Monitoring Compliance of Patients With Benzodiazepine Therapy Even After Hydrolyzing Glucuronide Metabolites in Urine to Increase Cross-Reactivity: Comparison of Immunoassay Results With LC-MS/MS Values (2015) (13)
- Interference of carbamazepine and carbamazepine 10,11-epoxide in the fluorescence polarization immunoassay for tricyclic antidepressants: estimation of the true tricyclic antidepressant concentration in the presence of carbamazepine using a mathematical model. (2004) (13)
- Analytical Performance of a New Liquid Chromatography/Tandem Mass Spectrometric Method for Determination of Everolimus Concentrations in Whole Blood (2012) (12)
- Interference of oleandrin and oleandrigenin in digitoxin immunoassays: minimal cross reactivity with a new monoclonal chemiluminescent assay and high cross reactivity with the fluorescence polarization assay. (1997) (12)
- Rapid detection of cardioactive bufalin toxicity using fluorescence polarization immunoassay for digitoxin. (1998) (12)
- Distinguishing Amphetamine, Methamphetamine and 3,4-Methylenedioxymethamphetamine from Other Sympathomimetic Amines After Rapid Derivatization with Propyl Chloroformate and Analysis by Gas Chromatography—Chemical Ionization Mass Spectrometry (1997) (12)
- Clinicopathological complexity in the application of the universal definition of myocardial infarction. (2019) (12)
- High-dose alpha-tocopherol therapy does not affect HDL subfractions in patients with coronary artery disease on statin therapy. (2007) (12)
- A rapid novel derivatization of amphetamine and methamphetamine using 2,2,2-trichloroethyl chloroformate for gas chromatography electron ionization and chemical ionization mass spectrometric analysis. (1998) (12)
- Introduction to Therapeutic Drug Monitoring. Frequently and Less Frequently Monitored Drugs (2012) (12)
- Effect of digoxin fab antibody on the measurement of total and free digitoxin by fluorescence polarization and a new chemiluminescent immunoassay. (1999) (12)
- Rapid detection of oleander poisoning by Dimension Vista digoxin assay (Flex Reagent Cartridge) (2011) (12)
- Hematology and Coagulation: A Comprehensive Review for Board Preparation, Certification and Clinical Practice (2015) (12)
- Natural Active Ingredients for Diabetes and Metabolism Disorders Treatment (2016) (11)
- A novel derivatization of ethylene glycol from human serum using 4-carbethoxyhexafluorobutyryl chloride for unambiguous gas chromatography-chemical ionization mass spectrometric identification and quantification. (1995) (11)
- Antiinflammatory Herbal Supplements (2019) (11)
- Mass spectrometry studies of a novel digoxin-like substance (DLIS-2) isolated from human plasma ultrafiltrate. (1988) (11)
- Gas chromatographic-mass spectrometric identification and quantitation of urinary phenols after derivatization with 4-carbethoxyhexafluorobutyryl chloride, a novel derivative. (1997) (11)
- The Fab fragment of anti-digoxin antibody (digibind) binds digitoxin-like immunoreactive components of Chinese medicine Chan Su: monitoring the effect by measuring free digitoxin. (2001) (11)
- Interaction of white and pink grapefruit juice with acetaminophen (paracetamol) in vivo in mice. (2008) (10)
- Effect of Chinese Medicines Chan Su and Lu-Shen-Wan on Serum Digoxin Measurement by Digoxin III, a New Digoxin Immunoassay (2008) (10)
- Interactions between drugs and Asian medicine: displacement of digitoxin from protein binding site by bufalin, the constituent of Chinese medicines Chan Su and Lu-Shen-Wan. (2000) (10)
- An improved microalbumin method (µALB_2) with extended analytical measurement range evaluated on the ADVIA® chemistry systems (2009) (10)
- Operator error: a critical determinant of false amikacin and tobramycin concentrations using fluorescence polarization immunoassay kits and TDX analyzer. (1999) (10)
- Unexpected suppression of free phenytoin concentration by salicylate in uremic sera due to the presence of inhibitors: MALDI mass spectrometric determination of molecular weight range of inhibitors. (1999) (10)
- Elevated lipid peroxidation products and depleted transferrin levels in the plasma of kidney transplant recipients. (1990) (10)
- Microwave-induced rapid hydrolysis of acetaminophen and its conjugates in urine for emergency toxicological screen. (1993) (10)
- Use of fluorescence polarization immunoassay for salicylate to avoid positive/negative interference by bilirubin in the Trinder salicylate assay (2003) (10)
- Estimating concentrations of total digoxin and digoxin-like immunoreactive substances in volume-expanded patients being treated with digoxin. (1996) (10)
- Effect of Indian Ayurvedic medicine Ashwagandha on measurement of serum digoxin and 11 commonly monitored drugs using immunoassays: study of protein binding and interaction with Digibind. (2007) (10)
- Elimination of fluconazole interference in gas chromatography/mass spectrometric confirmation of benzoylecgonine, the major metabolite of cocaine using pentafluoropropionyl derivative. (1996) (10)
- Interference of Endogenous Digoxin-Like Immunoreactive Factors in Serum Digoxin Measurement is Minimized in a New Turbidimetric Digoxin Immunoassay on ADVIA 1650 Analyzer (2004) (10)
- Gas chromatographic-mass spectrometric identification and quantitation of ethylene glycol in serum after derivatization with perfluorooctanoyl chloride: a novel derivative. (1995) (10)
- Challenges in Laboratory Detection of Unusual Substance Abuse: Issues with Magic Mushroom, Peyote Cactus, Khat, and Solvent Abuse. (2017) (10)
- Discordant carbamazepine values between two immunoassays: carbamazepine values determined by ADVIA centaur correlate better with those determined by LC‐MS/MS than PETINIA assay (2011) (10)
- Limitations of immunoassays used for therapeutic drug monitoring of immunosuppressants (2016) (9)
- Utility of VerifyNow for Point-of-Care Identification of an Aspirin Effect Prior to Emergency Cardiac Surgery. (2015) (9)
- A novel derivatization of phenol after extraction from human serum using perfluorooctanoyl chloride for gas chromatography-mass spectrometric confirmation and quantification. (1997) (9)
- Postmortem lipid levels for the analysis of risk factors of sudden death: usefulness of the Ektachem and Monarch analyzers. (1997) (9)
- New Enzyme-Linked Immunosorbent Digoxin Assay on the ADVIA® IMS™ 800i System Is Virtually Free from Interference of Endogenous Digoxin-like Immunoreactive Factors (2005) (9)
- Confirmation and quantitation of cocaine, benzoylecgonine, ecgonine methyl ester, and cocaethylene by gas chromatography/mass spectrometry. Use of microwave irradiation for rapid preparation of trimethylsilyl and T-butyldimethylsilyl derivatives. (1995) (9)
- Urinary adulterants and drugs-of-abuse testing. (2003) (9)
- Positive Bias in Mycophenolic Acid Concentrations Determined by the CEDIA Assay Compared to HPLC‐UV Method: Is CEDIA Assay Suitable for Therapeutic Drug Monitoring of Mycophenolic Acid? (2013) (8)
- A Health Educator's Guide to Understanding Drugs of Abuse Testing (2009) (8)
- New method for calcium on the ADVIA analyzer is free from interference of gadolinium‐type contrast agents (2009) (8)
- Microwave-induced rapid synthesis of 4-carbethoxyhexafluorobutyryl derivatives of fatty alcohols —a novel derivative for gas chromatography-chemical ionization mass spectrometric study (1995) (8)
- Falsely elevated serum digitoxin concentrations due to cross-reactivity of water-extractable digitoxin-like immunoreactivity of Chinese medicine Chan SU: elimination of interference by use of a chemiluminescent assay. (2000) (8)
- Cross-reactivity of fosphenytoin in four phenytoin immunoassays. (1998) (8)
- Use of alkaline phosphatase to correct the underestimation of fosphenytoin concentration in serum measured by phenytoin immunoassays. (1999) (8)
- Simultaneous determination of fenfluramine and phentermine in urine using gas chromatography mass spectrometry with pentafluoropropionic anhydride derivatization. (2000) (8)
- Activated Charcoal Is Effective But Equilibrium Dialysis Is Ineffective in Removing Oleander Leaf Extract and Oleandrin From Human Serum: Monitoring the Effect by Measuring Apparent Digoxin Concentration (2003) (8)
- Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin. (1998) (8)
- Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds. (1994) (8)
- St. John's wort does not interfere with therapeutic drug monitoring of 12 commonly monitored drugs using immunoassays (2006) (8)
- Gas chromatographic-mass spectrometric determination of serum mexiletine concentration after derivatization with perfluorooctanoyl chloride, a new derivative. (1998) (8)
- Hydroxyzine and Cetirizine Interfere With the PENTINA Carbamazepine Assay but Not With the ADVIA CENTEUR Carbamazepine Assay (2010) (8)
- Analytical Techniques for Measuring Concentrations of Therapeutic Drugs in Biological Fluids (2008) (8)
- Chapter 16 – Herbal and Other Dietary Supplements That Are Antioxidants (2014) (7)
- Chapter 12 – Fruits, Vegetables, and Nuts: Good Sources of Antioxidants (2014) (7)
- Adulteration of Drugs-of-Abuse Specimens (2005) (7)
- Biotin at High Concentration Interferes with the LOCI Digoxin Assay but the PETINIA Phenytoin Assay Is Not Affected. (2018) (7)
- Laboratory statistics and quality control (2021) (7)
- Performance evaluation of a new chemiluminescent cardiac troponin I assay (2000) (7)
- Diminished protein binding capacity of uremic sera for valproate following hemodialysis: role of free fatty acids and uremic compounds. (1996) (7)
- Contamination of Some Kratom Products with Salmonella. (2019) (7)
- Lysosomal Enzymuria in Protein Energy Malnutrition (1998) (7)
- Pharmacology of Commonly Abused Drugs (2010) (7)
- New Enzyme-Linked Chemiluminescent Immunosorbent Digoxin Assay Is Free From Interference of Chinese Medicine DanShen (2006) (7)
- Carbamazepine-salicylate interaction in normal and uremic sera: reduced interaction in uremic sera. (1995) (7)
- Introduction to Free Radicals and the Body’s Antioxidant Defense (2014) (7)
- Special Issues in Therapeutic Drug Monitoring in Patients With Uremia, Liver Disease, and in Critically Ill Patients (2016) (6)
- Effect of Spironolactone, Potassium Canrenoate and Their Common Metabolite Canrenone on Serum Digoxin Measurement by Digoxin III, a New Digoxin Immunoassay (2008) (6)
- Beating Drug Tests and Defending Positive Results: A Toxicologist's Perspective (2010) (6)
- Biotin: Pharmacology, Pathophysiology, and Assessment of Biotin Status (2019) (6)
- Unexpected suppression of total digoxin concentrations by cross-reactants in the microparticle enzyme immunoassay: elimination of interference by monitoring free digoxin concentration. (1998) (6)
- A new enzyme‐linked chemiluminescent immunosorbent digoxin assay is virtually free from interference of spironolactone, potassium canrenoate, and their common metabolite canrenone (2006) (6)
- Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: Role of alkaline phosphatase (2001) (6)
- High False‐Positive Rate for Monoclonal Gammopathy Using Capillary Electrophoresis (CAPILLARYS 2) Alone (2014) (6)
- Bidirectional (Negative/Positive) Interference of Oleandrin and Oleander Extract on a Relatively New LOCI Digoxin Assay Using Vista 1500 Analyzer (2014) (6)
- Personalized immunosuppression in transplantation : role of biomarker monitoring and therapeutic drug monitoring (2016) (6)
- Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis. (1991) (6)
- Liver Enzymes as Alcohol Biomarkers (2015) (6)
- Digitoxinlike and digoxinlike immunoreactivitis in sera of patients with uremia and liver disease as measured by fluorescence polarization immunoassays: poor correlation between digitoxinlike and digoxinlike immunoreactivities. (1997) (6)
- Bioinformatics Analysis to Determine Prognostic Mutations of 72 de novo Acute Myeloid Leukemia Cases from the Cancer Genome Atlas (TCGA) with 23 Most Common Mutations and no Abnormal Cytogenetics. (2015) (6)
- Use of microwave irradiation for rapid synthesis of perfluorooctanoyl derivatives of fatty alcohols, a new derivative for gas chromatography-mass spectrometric and fast atom bombardment mass spectrometric study (1994) (6)
- Uremic Sera Contain Inhibitors That Block Digitoxin‐Valproic Acid Interaction (2001) (6)
- Biochemical Tests and Staining Techniques for Microbial Identification (2017) (6)
- Alcohol a double-edged sword: Health benefits with moderate consumption but a health hazard with excess alcohol intake (2017) (6)
- Chapter 13 – Tumor Markers (2014) (6)
- Pharmacogenomics in clinical therapeutics (2012) (6)
- Clinically Insignificant Negative Interferences of Spironolactone, Potassium Canrenoate, and Their Common Metabolite Canrenone in New Dimension Vista LOCI Digoxin Immunoassay (2012) (6)
- Erratum to ‘Apoptosis is associated with an increase in saturated fatty acid containing phospholipids in the neuronal cell line, HN2-5′ [Biochim. Biophys. Acta 1304 (1996) 171–178] (1997) (6)
- Evaluation of an automated chemiluminescent immunoassay for complexed PSA on the Bayer ACS:180™ system (2003) (6)
- Sensitive methods for determination of free digitoxin concentration using digitoxin immunoassays: demonstration of elevated free digitoxin concentration caused by digitoxin-phenytoin interaction by applying these new techniques. (1999) (5)
- Alcohol and Its Biomarkers: Clinical Aspects and Laboratory Determination (2015) (5)
- Gas chromatography-electron ionization and chemical ionization mass spectrometric analysis of urinary phenmetrazine after derivatization with 4-carbethoxyhexafluorobutyryl chloride--a new derivative. (1998) (5)
- Herbal supplements : efficacy, toxicity, interactions with western drugs, and effects on clinical laboratory tests (2010) (5)
- Analytical Performance Evaluation of a New Cobas Tacrolimus Assay on Cobas e411 Analyzer: Comparison of Values Obtained by the CMIA Tacrolimus Assay and a Liquid Chromatography Combined with Tandem Mass Spectrometric Method. (2016) (5)
- Beating Drug Tests and Defending Positive Results: A General Overview (2010) (5)
- Interference from digitoxin-like immunoreactive factors reduced in a new monoclonal chemiluminescent digitoxin assay. (1998) (5)
- Performance evaluation of a new chemiluminescent assay for prostate specific antigen (2000) (5)
- Naproxen metabolites interfere with certain bilirubin assays: elimination of interference by using a Roche bilirubin assay on the Hitachi 917 analyzer. (2010) (5)
- Common poisonings including heavy metal poisoning (2021) (5)
- Comparison of free digoxin and total digoxin: extent of interference from digoxin-like immunoreactive substances (DLIS) in a fluorescence polarization assay. (1989) (5)
- Interference of Asian, American, and Indian (Ashwagandha) ginsengs in serum digoxin measurements by a fluorescence polarization immunoassay can be minimized by using a new enzyme-linked chemiluminescent immunosorbent or turbidimetric assay. (2009) (5)
- Chapter 8 – Cardiac Markers (2014) (5)
- Designer drugs including bath salts and spices (2017) (5)
- Biotin interference in TSH, FT4, and FT3 assays based on the LOCI technology: Identifying interference by dilution (2018) (5)
- Higher sensitivity of capillary electrophoresis in detecting hemoglobin A2'compared to traditional gel electrophoresis. (2012) (5)
- Monitoring Free Drug Concentration: Clinical Usefulness and Analytical Challenges (2016) (5)
- Quantitation of cocaine, benzoylecgonine, ecgonine methyl ester, and cocaethylene in urine and blood using gas chromatography-mass spectrometry (GC-MS). (2010) (5)
- Monitoring Free Mycophenolic Acid Concentration: Is There Any Clinical Advantage? (2016) (5)
- Chapter 13 – Tea, Coffee, and Chocolate: Rich Sources of Antioxidants (2014) (5)
- Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing. (2013) (5)
- Determination of phenmetrazine in urine by gas chromatography-mass spectrometry after liquid-liquid extraction and derivatization with perfluorooctanoyl chloride. (1997) (5)
- Gas chromatography-electron ionization and chemical ionization mass spectrometric analysis of serum mexiletine concentration after derivatization with 2,2,2-trichloroethyl chloroformate: a novel derivative. (1998) (5)
- Protein electrophoresis and immunofixation (2021) (5)
- Chapter 11 – Oxidative Stress Related to Other Diseases (2014) (5)
- Genetic polymorphisms of alcohol metabolizing enzymes associated with protection from or increased risk of alcohol abuse (2017) (5)
- Resolving erroneous reports in toxicology and therapeutic drug monitoring (2012) (5)
- Gas chromatographic-mass spectrometric identification and quantitation of benzyl alcohol from human serum and postmortem blood after derivatization with 4-carbethoxy hexafluorobutyryl chloride: a novel derivative. (1997) (4)
- Adulterants and drugs-of- abuse testing: an update. (2008) (4)
- Effect of plantain on therapeutic drug monitoring of digoxin and thirteen other common drugs (2006) (4)
- Methods of alcohol measurement (2017) (4)
- Immunoassay Platform and Designs (2014) (4)
- Alternative Herbal Immunomodulators and Drug Interactions (2003) (4)
- Preanalytical variables (2021) (4)
- A convenient derivatization method for gas chromatography/mass spectrometric determination of phenmetrazine in urine using 2,2,2-trichloroethyl chloroformate. (1998) (4)
- A Review of the Preanalytical Errors that Impact Therapeutic Drug Monitoring. (2021) (4)
- Impaired protein binding of Chinese medicine DanShen in uremic sera and sera with hyperbilirubinemia: Rapid assessment of total and free Danshen concentrations using the fluorescence polarization immunoassay for digoxin (2003) (4)
- Media for the Clinical Microbiology Laboratory (2017) (4)
- Analytical performance evaluation of ADVIA Chemistry Carbamazepine_2 assay: minimal cross‐reactivity with carbamazepine 10, 11‐epoxide and none with hydroxyzine or cetirizine (2010) (4)
- Link between environmental factors, personality factors, and addiction (2017) (4)
- The iDigoxin Assay is More Sensitive than LOCI Digoxin Assay for Rapid Detection of Convallatoxin, the Active Cardiac Glycoside of Lily of The Valley. (2015) (4)
- Fatty acid abnormalities in hemodialysis patients (1989) (4)
- Introduction to Therapeutic Drug Monitoring and Chromatography (2009) (4)
- Mathematical Equations to Calculate True Mycophenolic Acid Concentration in Human Plasma by Using Two Immunoassays With Different Cross‐Reactivities With Acyl Glucuronide Metabolite: Comparison of Calculated Values With Values Obtained by Using an HPLC‐UV Method (2013) (4)
- Tea, Coffee, and Chocolate (2014) (4)
- Effect of heating sera under conditions necessary for deactivation of human immunodeficiency virus on commonly monitored therapeutic drugs. (1994) (4)
- The New Enzyme-Linked Immunosorbent Digoxin Assay on the ADVIA Integrated Modular System® is Virtually Free From Oleander Interference (2006) (4)
- STABILITY OF THERAPEUTIC DRUGS ON SERUM SEPARATOR TUBES FROM BECTON-DICKINSON CONTAINING A NEW GEL FORMULATION. (1999) (4)
- Caffeine and theophylline (2020) (4)
- Stereospecificity of antibody: quinine, the optical isomer of quinidine and anti-malarial drug chloroquine do not cross-react with quinidine immunoassays. (2000) (4)
- Fruits, Vegetables, and Nuts (2014) (4)
- Diabetes and Oxidative Stress (2014) (4)
- Immunoassays for Therapeutic Drug Monitoring: Pitfalls and Limitations (2009) (4)
- Water, Homeostasis, Electrolytes, and Acid–Base Balance (2014) (4)
- Analytical performance of a new chemiluminescent phenytoin (ACS:180) assay. (1997) (4)
- Antigen and Antibody Testing (2017) (3)
- Limitations of Drugs of Abuse Testing (2013) (3)
- Digoxin Immunoassays on the ARCHITECT i2000SR and ARCHITECT c8000 Analyzers Are Free From Interferences of Asian, Siberian, and American Ginseng (2015) (3)
- Chapter 10 – Role of Oxidative Stress in Neurodegenerative Diseases and Other Diseases Related to Aging (2014) (3)
- Effect of spironolactone, potassium canrenoate, and their common metabolite canrenone on dimension Vista Digoxin Assay (2010) (3)
- β-Hexosaminidase, Acetaldehyde–Protein Adducts, and Dolichol as Alcohol Biomarkers (2015) (3)
- Alcohol Biomarkers: An Overview (2015) (3)
- Comparison of Response of DRI Oxycodone Semiquantitative Immunoassay With True Oxycodone Values Determined by Liquid Chromatography Combined With Tandem Mass Spectrometry: Sensitivity of the DRI Assay at 100 ng/ml Cut‐Off and Validity of Semiquantitative Value (2016) (3)
- Mean Corpuscular Volume and Carbohydrate-Deficient Transferrin as Alcohol Biomarkers (2015) (3)
- Effect of Herbal Remedies on Clinical Laboratory Tests (2013) (3)
- Chapter 4 – Oxidative Stress Caused by Cigarette Smoking, Alcohol Abuse, and Drug Abuse (2014) (3)
- Renal function tests. (1967) (3)
- Effectiveness of activated charcoal and equilibrium dialysis in removing Asian, American, Siberian and Indian ginseng from human serum. (2006) (3)
- Valproic acid-ketoconazole interaction in normal, hypoalbuminemic, and uremic sera: lack of interaction in uremic serum caused by the presence of inhibitor. (1997) (3)
- Digoxin-like immunoreactive substances in kidney- and liver-transplant patients. (1990) (3)
- Convallatoxin, the active cardiac glycoside of lily of the valley, minimally affects the ADVIA Centaur digoxin assay (2018) (3)
- Pharmacogenomics of Alcohol and Drugs of Abuse (2012) (3)
- Distinguishing ephedrine and pseudoephedrine from methamphetamine as 4-carbethoxyhexafluorobutyryl or pentafluorobenzoyl derivatives and analysis by GC/Cl-MS : microwave-induced rapid derivatization (1995) (3)
- Gas chromatographic/mass spectrometric identification and quantification of aniline after extraction from serum and derivatization with 4-carbethoxyhexafluorobutyryl chloride, a new derivative. (1999) (3)
- Pharmacologic agents in transfusion medicine (2018) (3)
- Direct Alcohol Biomarkers Ethyl Glucuronide, Ethyl Sulfate, Fatty Acid Ethyl Esters, and Phosphatidylethanol (2015) (3)
- Erratum: Curriculum content and evaluation of resident competency in clinical pathology (laboratory medicine): A proposal (Clinical Chemistry (2006) 52 (917-949)) (2006) (3)
- Validation of a Free Phenytoin Assay on Cobas c501 Analyzer Using Calibrators From Cobas Integra Free Phenytoin Assay by Comparing its Performance With Fluorescence Polarization Immunoassay for Free Phenytoin on the TDx Analyzer (2013) (3)
- Adsorption of charged non-albumin bound drugs by amorphous silica. (1995) (2)
- Significantly different fatty acid profiles in various phospholipid head groups of neuroblastoma cell lines. (1996) (2)
- Complete blood count and peripheral smear examination (2020) (2)
- Hemoglobin Wayne Trait with Incidental Polycythemia. (2017) (2)
- Differential effects of transition metal ions on in vitro lipid peroxidation of human serum and protein precipitated from serum. (1992) (2)
- Carbohydrate metabolism, diabetes, and hypoglycemia (2021) (2)
- Combined alcohol and drug abuse (2017) (2)
- Chapter 14 – Alcoholic Beverages: Antioxidant and Other Health Benefits of Moderate Consumption (2014) (2)
- Bone marrow examination and interpretation (2020) (2)
- Thrombophilias and Their Detection (2015) (2)
- Therapeutic Monitoring of Tacrolimus (FK 506) Using Liquid Chromatography. A Review (1995) (2)
- Pitfalls in testing for common tumor markers (2019) (2)
- Measurement of Alcohol Levels in Body Fluids and Transdermal Alcohol Sensors (2015) (2)
- PETINIA Total Phenytoin Assay on the Vista 1500 Analyzer Is Not Suitable for Monitoring Free Phenytoin Concentration if Ultrafiltration Is Performed at Room Temperature (2013) (2)
- Morphoproteomics Identifies SIRT1 and EZH2 Pathways as Commonalities in B-cell Acute Lymphoblastic Leukemia: Pathogenetic Implications and Opportunities for Therapeutic Intervention. (2017) (2)
- Effects of herbal supplements on clinical laboratory test results (2011) (2)
- Comparison of SemiQuantitative Cotinine Values Obtained by the DRI Immunoassay and Values Obtained by a Liquid Chromatography–Tandem Mass Spectrometry‐Based Method: The DRI Immunoassay is Suitable for Screening Purposes Only Because Semiquantitative Values May Be Unreliable (2016) (2)
- Hemoglobinopathies and thalassemias (2020) (2)
- Benign white blood cell and platelet disorders (2020) (2)
- The effect of yogurt on acetaminophen absorption by activated charcoal and burnt toast (2007) (2)
- Application of chromatographic techniques for therapeutic drug monitoring (2020) (2)
- Household Chemicals and Internet Based Products for Beating Urine Drug Tests (2010) (2)
- Effect of Chinese Medicines Chan Su, Asian Ginseng, Siberian Ginseng, and American Ginseng on a New Digoxin Immunoassay Based on Luminescent Oxygen Channeling Technology (2011) (2)
- Pharmacokinetics and therapeutic drug monitoring (2020) (2)
- Immunoassays and Issues With Interference in Therapeutic Drug Monitoring (2016) (2)
- Stability of oleander extract and oleandrin in sera stored in plastic serum separator tubes (2007) (2)
- GC/MS confirmation of urinary opiates by use of trimethylsilyl derivatives. (1988) (2)
- Model analysis of bidirectional interference in two-stage labeled-ligand immunoassays. (2017) (2)
- False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine. (2007) (2)
- COVID-19 Cardiac Injury: An Important Cause of COVID-19 Related Morbidityand Mortality. (2021) (2)
- How herbal remedies affect clinical laboratory test results. (2007) (2)
- Analytical True Positive (2019) (2)
- Digitoxin-like immunoreactivity in sera of mice after feeding with chinese medicine Chan Su: study of protein binding of Chan Su in normal sera, uremic sera and sera from patients with liver disease. (2001) (2)
- Genetic Aspects of Alcohol Metabolism and Drinking Behavior (2015) (2)
- Red cell antigens and antibody (2018) (2)
- Therapeutic drug monitoring of antimicrobial, antifungal and antiviral agents (2020) (2)
- Alcohol: Pharmacokinetics, Health Benefits With Moderate Consumption and Toxicity (2019) (2)
- Drugs of abuse (2017) (2)
- Effect of serum albumin on in vitro displacement of valproic acid by ceftriaxone and nafcillin. (1990) (2)
- Chapter 21 – Hemoglobinopathy (2014) (2)
- Coagulation-Based Tests and Their Interpretation (2016) (2)
- Lipid metabolism and disorders (2021) (1)
- Effect of Carbamazepine 10, 11-Epoxide on Serum Carbamazepine Measurement Using a New CMIA Assay: Comparison of Values Obtained by Using PETINIA, CEDIA and Liquid Chromatography Combined with Tandem Mass Spectrometry. (2016) (1)
- Therapeutic Drug Monitoring in Cancer Patients: Application of Chromatographic Techniques (2009) (1)
- Chapter 17 – Combating Oxidative Stress with a Healthy Lifestyle (2014) (1)
- Analytical Performance Evaluation of Aptima Herpes Simplex Virus 1 and 2 Assay Using Hologic Panther Instrument. (2020) (1)
- Zinc Sulfate, a Recently Introduced Urinary Adulterant Can Invalidate Urine Cotinine Test Using Immunoassay but Has Less Effect on Liquid Chromatography Combined With Tandem Mass Spectrometry–Based Test (2015) (1)
- Testing for ethyl alcohol (alcohol) and other volatiles (2021) (1)
- Psychological Stress-Induced Oxidative Stress (2014) (1)
- Analytical performance evaluation of a new turbidimetric immunoassay for valproic acid on the ADVIA® 1650 analyzer: effect of gross hemolysis and high bilirubin (2005) (1)
- Chapter 5 – Oxidative Stress Induced by Household Chemicals (2014) (1)
- Digitally enabled hemovigilance allows real time response to transfusion reactions (2022) (1)
- Therapeutic drug monitoring of cardioactive drugs (2020) (1)
- Interferences of Herbal Remedies with Immunoassays for Therapeutic Drugs: Focus on Digoxin (2010) (1)
- Taking Advantage of Assay Harmonization, Biotin Interference in the LOCI Digoxin Assay Could Be Eliminated by Using the ADVIA Centaur Digoxin Assay. (2018) (1)
- Challenges in Therapeutic Drug Monitoring of Digoxin Using Immunoassays (2012) (1)
- Pharmacogenomics of abused drugs (2017) (1)
- Abnormal Liver Function Tests Due to Hepatotoxic Herbs (2010) (1)
- Analytical True Positives in Workplace Drugs Testings Due to Use of Prescription and OTC Medications (2010) (1)
- False-positive ODA testing results due to prescription medications . (2009) (1)
- Hemoglobinopathies and thalassemia (2021) (1)
- Genetic Factors Associated With Opioid Therapy and Opioid Addiction (2020) (1)
- Immunoassay Design and Mechanism of Biotin Interference (2019) (1)
- Can Tranexamic Acid Reduce Blood Loss during Major Cardiac Surgery? A Pilot Study (2017) (1)
- Specimen Collection and Handling in Microbiology Laboratory (2017) (1)
- Sources of errors in hematology and coagulation (2020) (1)
- Monitoring Free Drug Concentration (2008) (1)
- Interferences in therapeutic drug monitoring (2021) (1)
- Technical Note: Negative Interference of Ashwagandha, an Indian Ayurveda Medicine Indicated for Preventing COVID-19, in IL-6 Immunoassay. (2022) (1)
- Pharmacotherapy With Antiplatelet, Anticoagulant, and Their Reversing Agents (2016) (1)
- T Cell and Natural Killer Cell Lymphomas (2015) (1)
- Application of flow cytometry in diagnosis of hematological disorders (2020) (1)
- Toxic herbals and plants in the United States (2020) (1)
- Effect of Biotin on Clinical Laboratory Test Results (2019) (1)
- Crude Opium, Morphine, Codeine, and Heroin: Past and Present (2020) (1)
- The New LOCI Digoxin Assay on the Vista 1500 Analyzer Is Virtually Free From Interferences of Herbal Supplements Hawthorn and Ashwagandha (Indian Ginseng) (2012) (1)
- Oxidative Stress and Cancer (2014) (1)
- Suitability of the DRI Hydrocodone/Hydromorphone Immunoassay in the Clinical Environment at a Lower Cutoff: Validation With LC-MS/MS Analysis (2016) (1)
- Clinical utility of monitoring unbound (free) drug concentration (2003) (1)
- Application of Molecular Diagnostics (2017) (1)
- Free drug monitoring in therapeutics. (2003) (1)
- Pre-Analytical Variables (2014) (1)
- Adulterating Hair, Oral Fluid, and Sweat Specimens for Drug Testing (2010) (1)
- Drug–Herb and Drug–Food Interactions (2008) (1)
- Overview of Molecular Diagnostics Principles (2017) (1)
- Association between polymorphisms in genes encoding various receptors, transporters, and enzymes and alcohol/drug addiction (2017) (1)
- Chapter 3 – Oxidative Stress Induced by Air Pollution and Exposure to Sunlight (2014) (1)
- Thrombophilia and their detection (2020) (1)
- Blood Bank Testing and Blood Products (2016) (1)
- Specific Clinical Situations (2016) (1)
- Monoclonal Gammopathy and Its Detection (2015) (1)
- Immunoassay design and issues of interferences (2021) (1)
- 6: Utility of VerifyNow for Point-of-Care Identification of Aspirin and Clopidogrel Effects and Prediction of Bleeding Risk Prior to Emergency Cardiac Surgery (2015) (1)
- Prevalence of Howell-Jolly body-like inclusions in HIV patients and their correlation with CD4 counts and HIV RNA viral load. (2015) (1)
- Prescription Opioids: An Overview (2020) (1)
- Defending Positive Amphetamine Results (2010) (1)
- Therapeutic drug monitoring of antidepressants and psychoactive drugs (2020) (1)
- Designer drugs, date rape drugs, LSD, volatiles, magic mushroom, and peyote cactus abuse (2021) (1)
- Challenges in Therapeutic Drug Monitoring of Digoxin and Other Anti-Arrhythmic Drugs (2012) (1)
- Therapeutic Drug Monitoring of Vancomycin and Aminoglycosides with Guidelines (2009) (1)
- Chapter 14 – Therapeutic Drug Monitoring (2014) (1)
- Analysis of drugs of abuse in serum, hair, oral fluid, sweat, and meconium (2017) (1)
- Capillary Electrophoresis Quantification of Hb A2 in the Setting of Hb SS or Hb S / 20-thalassemia is More Accurate than HPLC (2013) (1)
- Therapeutic drug monitoring using alternative specimens (2020) (1)
- Genetic Markers of Alcohol Use Disorder (2015) (1)
- Essentials of coagulation (2020) (1)
- Digoxin so many interferences and how to eliminate them (2008) (1)
- Bidirectional (Negative/Positive) Interference of Oleandrin and Oleander Extract on a Relatively New LOCI Digoxin Assay (2013) (1)
- B-cell lymphomas (2020) (0)
- Laboratory methods for measuring drugs of abuse in urine (2017) (0)
- Water homeostasis electrolytes and acid-base balance (2021) (0)
- Synthetic Urine, Flushing, Detoxifying, and Related Agents for Beating Urine Drug Tests: Are They Effective? (2010) (0)
- Chan Su Interferes With LOCI Digoxin Assay, But Asian, Siberian, and American Ginseng Have No Effect (2012) (0)
- Effects of cupric and ferric ions on in vitro lipid peroxidation of human serum (1991) (0)
- Viruses Including Human Immunodeficiency Virus (2017) (0)
- A Morphoproteomic Study of Metformin and Vorinostat, Alone and in Combination, Induced Apoptosis in MOLT-4 Acute Leukemia Cells (2017) (0)
- Environmental Factors Linked to Opioids, Drugs, and Alcohol Abuse (2020) (0)
- Eczema and neurological disorders in association with malabsorption syndrome. (1969) (0)
- Indian Ayurvedic Medicines: An Introduction (2010) (0)
- Instrumentation and analytical methods (2021) (0)
- Laboratory Management and Administration (2017) (0)
- Subject Index, Vol. 11, 1991 (1991) (0)
- Comparison of LOCI Digoxin Assay and iDigoxin Assay for Rapid Detection of Convallatoxin, the Active Glycoside of the Lily of the Valley Plant (2015) (0)
- 9. Heavy metal toxicity due to use of Oriental and Ayurvedic medicines (2011) (0)
- Poppy Seed Defense and Workplace Drug Testing: Does It Work in the Court? (2020) (0)
- Special transfusion situations (2018) (0)
- Immunoassay design and biotin interference. (2022) (0)
- Merits of Monitoring Free Carbamazepine Measurements with an Automated Method. (2020) (0)
- Technical Note: Newly Reformulated Total and Free PSA Immunoassay on Cobas e411 Analyzer Is Virtually Free from Biotin Interference. (2022) (0)
- 5. Interaction of St. John’s wort with various drugs (2011) (0)
- Contents, Vol. 11, 1991 (1991) (0)
- Special concern (2019) (0)
- Donor selection and testing (2018) (0)
- Chapter 6 – Psychological Stress-Induced Oxidative Stress: Differences Between Personality Types, Gender, and Race (2014) (0)
- Defending Positive Opiate and Marijuana Test Results (2010) (0)
- Autoimmunity, complement, and immunodeficiency (2021) (0)
- Clinical utility of monitoring free drug levels (2020) (0)
- 2. Abnormal liver function tests due to use of herbal supplements (2011) (0)
- A Comprehensive Guide (2012) (0)
- Investigation of Drug–Herb Interactions: Application of various Chromatographic Techniques for Analysis of Active Components of Herbal Supplements (2009) (0)
- 11. Toxic and dangerous herbs (2011) (0)
- Systolic time intervals in aortic stenosis. Differential diagnosis of heart failure. (1977) (0)
- Red blood cell disorders (2020) (0)
- Problems with Digoxin Immunoassays (2009) (0)
- Monoclonal gammopathies and their detection (2020) (0)
- Pharmacogenomics and therapeutic drugs monitoring: Are they complementary? (2020) (0)
- Miscellaneous Issues (2019) (0)
- Doctor and his environment. (1971) (0)
- Analgesics (2020) (0)
- Pharmacokinetics of Acetaminophen in Hind Limbs Unloaded Mice: A Model System Simulating the Effects of Low Gravity on Astronauts in Space (2008) (0)
- 8. Interactions between fruit juices and drugs: clinical impact (2011) (0)
- Chromatographic Techniques for Therapeutic Drug Monitoring of Antiretroviral Drugs (2009) (0)
- Cytogenetic Abnormalities and Hematologic Neoplasms (2015) (0)
- Issues of Interferences in Therapeutic Drug Monitoring (2019) (0)
- Abuse of Magic Mushrooms, Peyote Cactus, Khat, and Solvents: No Readily Available Laboratory Tests (2012) (0)
- Distortions but not Definitive Peaks by Capillary Serum Protein Electrophoresis Indicate Monoclonal Gammopathy of Undetermined Significance rather than Multiple Myeloma. (2020) (0)
- Overview of Fungal Infections (2017) (0)
- Less Commonly Used Alcohol Biomarkers and Proteomics in Alcohol Biomarker Discovery (2015) (0)
- Effect of Biotin on Cardiac Troponin I and High Sensitivity Cardiac Troponin I Assays on Vista 1500 and ADVIA Centaur Analyzer. (2021) (0)
- Abstract/Case Study Review Committee for the College of American Pathologists 2017 Annual Meeting (CAP17). (2017) (0)
- 28 Intraoperative Administration of Antifibrinolytic Drug Tranexamic Acid Is Not Associated with Decreased Intraoperative Blood Loss During Major Cardiac Surgery (2018) (0)
- Therapeutic Drug Monitoring of Immunosuppressants: Limitations of Immunoassays and the Need for Chromatographic Methods (2012) (0)
- Chapter 7 – Oxidative Stress and Cardiovascular Diseases (2014) (0)
- Lymphoproliferative disorders associated with immune deficiencies, histiocytic and dendritic cell neoplasms, and blastic plasmacytoid dendritic cell neoplasm (2020) (0)
- Pitfalls in Tumor Markers Testing (2013) (0)
- Biotin: From Supplement to Therapy (2019) (0)
- Blood components: Processing, characteristics, and modifications (2018) (0)
- Effects of bilirubin, lipemia, hemolysis, paraproteins and heterophilic antibodies on immunoassays for therapeutic drug monitoring (2020) (0)
- Pharmacogenomics and the Toxicology Laboratory (2012) (0)
- True‐Positive Drugs of Abuse Test Results Due to Use of Prescriptions and Nonprescription Drugs (2012) (0)
- 108 STABILITY DIGOXIN AND DIGITOXIN IN SPECIMENS COLLECTED IN VACUTAINER BLOOD COLLECTION TUBE (1997) (0)
- Issues of Interferences in Clinical Chemistry Tests Including Heterophilic Antibody Interferences (2019) (0)
- Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase. (2000) (0)
- Technical Note: Bimodal Negative Interference of Biotin in Roche IL-6 Immunoassay. (2022) (0)
- Above-Normal Urinary Excretion of Albumin and Retinol-Binding Protein In Patients with Acute Myocardlal infarction (2004) (0)
- Infections Caused by Parasites (2017) (0)
- 10. Contamination of herbal supplements with Western drugs (2011) (0)
- 4. Interferences in digoxin immunoassays by various herbal supplements (2011) (0)
- Inability to Measure M‐Protein With Capillary Zone Electrophoresis (CAPPILLARYS 2) in Tracings With NonDiscernable Peaks (2015) (0)
- Preoperative Assessment of Patients (2016) (0)
- Approaches for Eliminating Interference/ Discordant Specimens in Therapeutic Drug Monitoring and Drugs of Abuse Testing (2012) (0)
- Drug–herb and drug–food interactions and effects on therapeutic drug monitoring (2020) (0)
- Vasodilator therapy in mitral regurgitation with chronic heart failure. (1978) (0)
- Muscular dystrophy with cardiac involvement. (1958) (0)
- Analytical Performance Evaluation of EMIT # { 174 } II Monoclonal Amphetamine / Methamphetamine Assay : More Specificitythan EMIT # { 174 } d . a . u . TMMonoclonal Amphetamine / Methamphetamine Assay (2004) (0)
- Increased Rate of False Positivity for Monoclonal Gammopathy Using Capillary Electrophoreses Alone, Compared With Traditional Gel Electrophoresis (2012) (0)
- Specific Clinical Infections (2017) (0)
- Cycler Stability of Nt-probnp in Serum Specimens Collected (0)
- Technical Note: Analytical Performance Evaluation of Electrochemiluminescence Cyclosporine Assay on Cobas e411 Analyzer. (2019) (0)
- Precursor lymphoid neoplasms, blastic plasmacytoid dendritic cell neoplasm, and acute leukemias of ambiguous lineage (2020) (0)
- Intraoperative and Postoperative Assessment and Management of Coagulopathy (2016) (0)
- Challenges in Drugs of Abuse Testing (2012) (0)
- Interference in Immunoassays Used for Monitoring Anticonvulsants and the Usefulness of Monitoring Free Anticonvulsants (2012) (0)
- Opioid Abuse and Opioid Epidemic (2020) (0)
- Inborn errors of metabolism (2021) (0)
- Significant Improvement in Digoxin Immunoassays Over Four Decades: Newer Assays are Less Affected by Interferences (2023) (0)
- Comment on increased erythrocyte susceptibility to lipid peroxidation in myeloproliferative disorders. (1984) (0)
- Treatment of muscular dystrophy with laevadosin. (1969) (0)
- High-Performance Liquid Chromatography in the Analysis of Active Ingredients in Herbal Nutritional Supplements (2007) (0)
- Benign lymph node (2020) (0)
- RAPID BUT IN INCOMPLETE IN VITRO CONVERSION OF FOSPHENYTOIN INTO PHENYTOIN IN SERA OF PATIENTS WITH LIVER DISEASE : ROLE OF ALKALINE PHOSPHATASE. (1999) (0)
- Sources of errors in transfusion medicine (2018) (0)
- Decision Support Software for Coagulopathy (2016) (0)
- Plant Poisoning and the Clinical Laboratory (2012) (0)
- Free Drug Monitoring (2011) (0)
- Traditional Therapeutic Drug Monitoring and Pharmacogenomics: Are They Complementary? (2012) (0)
- Human immunodeficiency virus (HIV) and hepatitis testing (2021) (0)
- T- and natural killer–cell lymphomas (2020) (0)
- 107 Interference of digitoxin-like immunoreactive factors in digitoxin immunoassays (1997) (0)
- Chapter 9 – Endocrinology (2014) (0)
- Myeloid neoplasms (2020) (0)
- Introduction to quality management system (2018) (0)
- Can spironolactone and canrenone interference in digoxin assays be eliminated by ultrafiltration? (multiple letters) (2003) (0)
- Unexplained hemolytic anemia with multiorgan failure: Commentary (2011) (0)
- 3. Kelp and thyroid panel tests (2011) (0)
- Biotin interferences with immunoassays (2021) (0)
- Benign Lymph Nodes (2015) (0)
- 1. Commonly used herbal supplements (2011) (0)
- Therapeutic drug monitoring (2021) (0)
- Challenges in Drugs of Abuse Testing: Magic Mushrooms, Peyote Cactus, and Designer Drugs (2014) (0)
- Role of the Laboratory in Detecting Other Poisoning, Including Pesticides, Ethylene Glycol, and Methanol (2012) (0)
- Preface (2020) (0)
- Issues of Interference in Drugs of Abuse Testing and Toxicology (2019) (0)
- Lymphoproliferative Disorders Associated with Immune Deficiencies and Histiocytic and Dendritic Cell Neoplasms (2015) (0)
- 6. Herbs to avoid with warfarin therapy (2011) (0)
- Effect of herbal supplements on clinical laboratory test results (2021) (0)
- Homeopathic Medicine: Principle, Efficacy, and Toxicity (2010) (0)
- Sources of Erroneous Results in Therapeutic Drug Monitoring Due to Preanalytical Errors, High Bilirubin, Hemolysis, and Lipids (2012) (0)
- A Morphoproteomic Study of Metformin and Vorinostat, Alone and in Combination, Induced Apoptosis in MOLT-4 Acute Leukemia Cells. (2017) (0)
- Effects of Hind Limb Unloading on Pharmacokinetics of Procainamide in Mice (2007) (0)
- Effect of Chinese Medicine Danshen and Indian Ayurvedic Medicine Bark of Arjuna Tree on a Relatively New LOCI Digoxin Assay for Application on the Vista 1500 Analyzer (2015) (0)
- Alcohol: Use, Abuse, and Issues with Blood Alcohol Level (2015) (0)
- Blood components: Transfusion practices (2018) (0)
- Chapter 20 – Pharmacogenomics (2014) (0)
- Limitations of Blood Alcohol Measurements Using Automated Analyzers and Breath Analyzers (2012) (0)
- Poisoning with Warfarin and Superwarfarin: What Can Laboratory Testing Do? (2012) (0)
- Cardiac markers (2021) (0)
- Blood bank testing (2018) (0)
- List of Contributors (2019) (0)
- Antiepileptic-drugs (2019) (0)
- Drugs of Abuse, Analysis of (2000) (0)
- Liver diseases and liver function tests (2021) (0)
- Effect of Drug–Herb Interactions on Therapeutic Drug Monitoring (2012) (0)
- List of contributors (2019) (0)
- List of contributors (2020) (0)
- Before and after: The pre-analytical and post-analytical phases of TDM (2020) (0)
- Comprar Pharmacogenomics In Clinical Therapeutics | Amitava Dasgupta | 9780470657348 | Wiley (2012) (0)
- Interference in Immunoassays Used to Monitor Tricyclic Antidepressants (2012) (0)
- Turbidimetric carbamazepine immunoassay on the ADVIA® 1650 and 2400 analyzers is free from interference of antihistamine drugs hydroxyzine and cetirizine (2007) (0)
- Analgesics: From Chemistry and Pharmacology to Clinical Applications. H. Buschmann, T. Christoph, E. Friderichs, C. Maul, and B. Sundermann, eds. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 2002, 604 pp., $185.00, hardcover. ISBN 3-527304-03-7. (2003) (0)
- An Introduction to Tests Performed in Toxicology Laboratories (2012) (0)
- Alcohol: Use and Abuse (2012) (0)
- Overutilization of Test for Hemoglobinopathy Evaluation: Experience from a Tertiary Care Academic Medical Center. (2019) (0)
- Antiplatelets and Anticoagulants (2016) (0)
- Effects of digoxin-like immunoreactive substance (DLIS) on sodium and calcium transport in culture smooth muscle and kidney cells (1987) (0)
- False‐Positive Results Using Immunoassays for Drugs of Abuse Testing (2012) (0)
- When Toxicology Report Is Negative in a Suspected Overdosed Patient: The World of Designer Drugs (2012) (0)
- Drugs of abuse testing (2021) (0)
- Distortion of Capillary Serum Protein Electrophoresis Pattern May Indicate Monoclonal Gammopathy of Undetermined Significance but Not Multiple Myeloma (2018) (0)
- 7. Interaction of ginseng, ginkgo, garlic and ginger supplements with various drugs (2011) (0)
- Interactions Between Fruit Juices and Drugs (2010) (0)
- Application of Flow Cytometry in the Diagnosis of Hematological Disorders (2015) (0)
- Hemoglobin Wayne: Case Study of a Rare Entity (2016) (0)
- Antineoplastic drugs (2022) (0)
- Point-of-care testing (2021) (0)
- Tumor markers (2021) (0)
- Pharmacogenomics (2021) (0)
- Patient blood management and utilization (2018) (0)
- Cytogenetic and genetic abnormalities in hematologic neoplasms (2020) (0)
- Immunosuppressants (2022) (0)
- Workplace Drug Testing: SAMHSA and Non-SAMHSA Drugs (2010) (0)
- Defending Positive Cocaine Tests (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Amitava Dasgupta?
Amitava Dasgupta is affiliated with the following schools:
